| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |